The onco clinic I made write off The balance sheet for the third quarter amounted to R$1.8 billion. Of this, 466.2 million reais was sale three hospital It is located in rio de janeiro, Uberlandia and Belo Horizonte; owes 183.2 million reais cancel from Construction of two “cancer centers” It was announced that it will operate from July to September in the capitals of Rio de Janeiro and Minas Gerais states.
There was also a provision for 100% repayment of debt of R$864.9 million. Unimed Felji CDB with Oncoclinics holds an additional R$ 217 million in reserves master bankwho is your partner? This amount corresponds to approximately 40% of the outstanding investments in financial institutions, which were added to the company’s capital last year through a capital increase of 1 billion reais.
- Check out the results and metrics. onco clinic Other listed companies on the Valor Empresas 360 portal
There are also other smaller provisions totaling R$67 million.
“All these measures were announced in the same quarter. As a result, we have already decided to start the fourth quarter with clean numbers to clean up our accounts and provide greater clarity on our operating performance,” he said. Cristiano Camargo, finance director Oncon Clinics’ public relations activities for investors.
In this scenario, the company published adjusted and unadjusted metrics.
The revenue Net profit fell by 13.6% to R$1.4 billion due to the breakup with main operating company Unimed Ferri, which was responsible for 13% of revenue. Currently, the medical cooperative and OncoClinics maintain a commercial relationship, but Unimed prepays for medical procedures to avoid default.
Earnings before interest, taxes, depreciation and amortization (Evida) decreased by almost 1.4 billion reais, compared to a profit of 263 million reais in the same period last year. Adjusted for accounting amortization, the indicator totaled R$ 241.4 million, a decrease of 20.3% compared to the same period in 2024. Adjusted EBITDA margin decreased by 1.4 percentage points to 17.1%.
According to Camargo, the sale of these three hospitals helped improve profit margins, as they were losing R$26 million per quarter. Comparing Q2 and Q3 (already excluding hospitals), EBITDA increased by R$56 million.
The director emphasized that the improvement in EBITDA, adjusted for accounting write-downs, will result in operating cash flow reaching R$246 million, 24% higher than in the same period last year. “Free cash flow totaled 62.4 million reais,” the executive said.
Reversal from profit to loss
On the last line of the balance sheet, the company prejudice Profit was R$1.8 billion, a reversal of R$3.1 million. Taking into account adjustments, the company posted a loss of R$97.9 million in the same quarter of 2024, compared to a profit of R$8.9 million. “There are financial cost implications here,” Camargo explained.
Leverage could drop to 2.6 times after Vila da Sera Hospital is sold for 130 million reais and the 160 million reais Uberlandia Hospital debt assumed by the buyer is eliminated, the people said.
“We believe we are in the final ‘turnaround’ process. We sold three hospitals in three months, had two cancellations and one capital increase. This is a major transformation,” Camargo said.
The company also increased its capital in the third quarter, raising 1.4 billion reais. This contribution reduces OncoClinics’ leverage to 4.2x and EBITDA to 3x. Debt was reduced from R$4 billion to R$2.9 billion.
The CedarA company that was a partner of OncoClinics in the “Cancer Center” project participated in the capital increase, investing 210 million reais. This amount refers to the cancellation penalty that Oncoclinics has to pay, but to avoid a cash outflow, it has chosen to turn this amount into a financial instrument that gives it the right to participate in the capital increase. Sedro, or an entity associated with Lucas Callas’ company, would own about 6.5% of Oncoclinics.
The new shareholder structure is expected to be announced in the coming days. Still, Master, Centauro, Latace and Goldman Sachs did not participate in the capital raise until mid-week, according to people familiar with the matter. The deadline to participate in the deal ended this Friday (14th).
About The Author
